Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCA subcutaneous sufentanil versus morphine for advanced cancer pain
ChiCTR-IPR-17011280Phase 4Recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- May 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cancer pain comparing Subcutaneous morphine with Subcutaneous sufentanil (2 arms). Primary endpoint: VAS pain score. Started May 2017; status: recruiting.
02
Drugs
sufentanilmorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR-IPR-17011280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011280.